/ACCA
ACCA Stock - Acacia Diversified Holdings, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • May 5
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.44
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ACCA
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.55
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|
| Revenue | $519,221 | $415,051 | $478,231 | $311,283 | $255,508 |
| Gross Profit | $25,322 | $138,741 | $236,888 | $72,300 | $123,422 |
| Gross Margin | 4.9% | 33.4% | 49.5% | 23.2% | 48.3% |
| Operating Income | $-996,411 | $-1,419,804 | $-1,397,997 | $-1,742,119 | $-611,820 |
| Net Income | $-1,710,487 | $-1,712,703 | $-1,833,728 | $-1,785,114 | $-611,819 |
| Net Margin | -329.4% | -412.6% | -383.4% | -573.5% | -239.5% |
| EPS | $-0.05 | $-0.09 | $-0.11 | $-0.11 | $-0.04 |
Company Overview
Acacia Diversified Holdings, Inc. engages in the extraction and processing of high-CBD/low-THC content medical grade hemp oils from medical hemp plants in the United States. The company is also involved in the research and development of botanicals endocannabinoid nutraceuticals product line; and retail and wholesale distribution of medicinal hemp products and dietary supplements. In addition, it offers consumer products under the EUFLORIA brand name for the distribution channels. The company was formerly known as Acacia Automotive, Inc. and changed its name to Acacia Diversified Holdings, Inc. in October 2012. Acacia Diversified Holdings, Inc. was incorporated in 1984 and is based in Clearwater, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
ACCABeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.01
Q2 2020
EPS Surprise History
Q4 18
No data
Q4 18
No data
Q1 19
No data
Q2 19
No data
Q3 19
No data
Q4 19
No data
Q2 20
No data
Q2 20
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2020 | Jun 30, 2020 | — | $0.01 | — | — |
Q2 2020 | Jun 26, 2020 | — | $-0.01 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-0.01 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.02 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.02 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.01 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.01 | — | — |
Q4 2018 | Nov 5, 2018 | — | $-0.02 | — | — |
Q3 2018 | Aug 13, 2018 | — | $-0.03 | — | — |
Q2 2018 | May 7, 2018 | — | $-0.02 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.03 | — | — |
Q4 2017 | Nov 13, 2017 | — | $-0.01 | — | — |
Q3 2017 | Aug 7, 2017 | — | $-0.03 | — | — |
Q2 2017 | May 10, 2017 | — | $-0.04 | — | — |
Q1 2017 | Mar 28, 2017 | — | $-0.05 | — | — |
Q4 2016 | Nov 14, 2016 | — | $-0.02 | — | — |
Q3 2016 | Aug 15, 2016 | — | $-0.02 | — | — |
Q2 2016 | May 13, 2016 | — | $-0.02 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.02 | — | — |
Q4 2015 | Nov 10, 2015 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about ACCA
What is ACCA's current stock price?
Acacia Diversified Holdings, Inc. (ACCA) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for ACCA?
No analyst price targets are currently available for this stock.
What sector is Acacia Diversified Holdings, Inc. in?
Acacia Diversified Holdings, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is ACCA's market cap?
Acacia Diversified Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does ACCA pay dividends?
No, Acacia Diversified Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorABMC
American Bio Medica Corporation
$0.00
Mkt Cap: $0.0B
AHPIQ
Allied Healthcare Products, Inc.
$0.00
Mkt Cap: $0.0B
CRXM
Gene Biotherapeutics, Inc.
$0.00
Mkt Cap: $0.0B
CRYO
American CryoStem Corporation
$0.00
Mkt Cap: $0.0B
DMTKQ
DermTech, Inc.
$0.00
Mkt Cap: $0.0B
EQUR
E-Qure Corp.
$0.00
Mkt Cap: $0.0B
FPSUF
Capha Pharmaceuticals Inc.
$0.00
Mkt Cap: $0.0B
GTHR
GeneThera, Inc.
$0.00
Mkt Cap: $0.0B
RXEI
RxElite, Inc.
$0.00
Mkt Cap: $0.0B
TAUG
Tauriga Sciences, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to ACCA for comparison